QDEL
Price
$44.85
Change
+$1.82 (+4.23%)
Updated
Dec 20, 04:59 PM (EDT)
52 days until earnings call
SRTS
Price
$7.09
Change
-$0.12 (-1.66%)
Updated
Dec 20, 04:59 PM (EDT)
46 days until earnings call
Ad is loading...

QDEL vs SRTS

Header iconQDEL vs SRTS Comparison
Open Charts QDEL vs SRTSBanner chart's image
QuidelOrtho
Price$44.85
Change+$1.82 (+4.23%)
Volume$18.12K
CapitalizationN/A
Sensus Healthcare
Price$7.09
Change-$0.12 (-1.66%)
Volume$3.84K
CapitalizationN/A
QDEL vs SRTS Comparison Chart
Loading...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QDEL vs. SRTS commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QDEL is a Hold and SRTS is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (QDEL: $44.84 vs. SRTS: $7.10)
Brand notoriety: QDEL and SRTS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: QDEL: 193% vs. SRTS: 109%
Market capitalization -- QDEL: $3.14B vs. SRTS: $61.97M
QDEL [@Medical Specialties] is valued at $3.14B. SRTS’s [@Medical Specialties] market capitalization is $61.97M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QDEL’s FA Score shows that 1 FA rating(s) are green whileSRTS’s FA Score has 0 green FA rating(s).

  • QDEL’s FA Score: 1 green, 4 red.
  • SRTS’s FA Score: 0 green, 5 red.
According to our system of comparison, both QDEL and SRTS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QDEL’s TA Score shows that 6 TA indicator(s) are bullish while SRTS’s TA Score has 5 bullish TA indicator(s).

  • QDEL’s TA Score: 6 bullish, 3 bearish.
  • SRTS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QDEL is a better buy in the short-term than SRTS.

Price Growth

QDEL (@Medical Specialties) experienced а +8.44% price change this week, while SRTS (@Medical Specialties) price change was -12.99% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

QDEL is expected to report earnings on Feb 12, 2025.

SRTS is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QDEL($3.14B) has a higher market cap than SRTS($62M). SRTS has higher P/E ratio than QDEL: SRTS (126.00) vs QDEL (9.76). SRTS YTD gains are higher at: 200.847 vs. QDEL (-39.159). QDEL has higher annual earnings (EBITDA): 607M vs. SRTS (79K). QDEL has more cash in the bank: 167M vs. SRTS (23.1M). SRTS has less debt than QDEL: SRTS (783K) vs QDEL (2.61B). QDEL has higher revenues than SRTS: QDEL (3B) vs SRTS (24.4M).
QDELSRTSQDEL / SRTS
Capitalization3.14B62M5,068%
EBITDA607M79K768,354%
Gain YTD-39.159200.847-19%
P/E Ratio9.76126.008%
Revenue3B24.4M12,287%
Total Cash167M23.1M723%
Total Debt2.61B783K333,844%
FUNDAMENTALS RATINGS
QDEL vs SRTS: Fundamental Ratings
QDEL
SRTS
OUTLOOK RATING
1..100
957
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
60
Fair valued
PROFIT vs RISK RATING
1..100
10071
SMR RATING
1..100
9749
PRICE GROWTH RATING
1..100
4638
P/E GROWTH RATING
1..100
15100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QDEL's Valuation (57) in the Medical Specialties industry is in the same range as SRTS (60). This means that QDEL’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's Profit vs Risk Rating (71) in the Medical Specialties industry is in the same range as QDEL (100). This means that SRTS’s stock grew similarly to QDEL’s over the last 12 months.

SRTS's SMR Rating (49) in the Medical Specialties industry is somewhat better than the same rating for QDEL (97). This means that SRTS’s stock grew somewhat faster than QDEL’s over the last 12 months.

SRTS's Price Growth Rating (38) in the Medical Specialties industry is in the same range as QDEL (46). This means that SRTS’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for SRTS (100). This means that QDEL’s stock grew significantly faster than SRTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QDELSRTS
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GQEPX22.820.14
+0.62%
GQG Partners US Select Quality Eq Inv
IOVFX13.610.04
+0.29%
GMO International Opportunistic Val I
ARSVX15.360.04
+0.26%
AMG River Road Small Cap Value N
MIZIX7.800.02
+0.26%
MassMutual International Eq I
CEUFX52.92-0.17
-0.32%
American Funds Europacific Growth 529F1

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with IQV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
+4.21%
IQV - QDEL
45%
Loosely correlated
+3.00%
CERS - QDEL
42%
Loosely correlated
N/A
TWST - QDEL
40%
Loosely correlated
+9.90%
ILMN - QDEL
37%
Loosely correlated
+1.51%
IART - QDEL
37%
Loosely correlated
+0.41%
More

SRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
-1.53%
LUNG - SRTS
57%
Loosely correlated
+3.71%
VAPO - SRTS
35%
Loosely correlated
N/A
QDEL - SRTS
27%
Poorly correlated
+4.21%
NVST - SRTS
25%
Poorly correlated
+3.72%
NNOX - SRTS
24%
Poorly correlated
+2.89%
More